Benoit Beuselinck

Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial

Robert J. Motzer, Brian I. Rini, David F. McDermott et al. · The Lancet Oncology · 2019 · 763 citations · Full text

Urology, Genitourinary Cancer, Medicine +8

Cytoreductive Nephrectomy in Patients with Synchronous Metastases from Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

Daniel Y.C. Heng, J. Connor Wells, Brian I. Rini et al. · European Urology · 2014 · 467 citations · Full text

Urology, Surgical Oncology, Genitourinary Cancer +7

Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated with Sunitinib Response in the Metastatic Setting

Benoit Beuselinck, Sylvie Job, Étienne Becht et al. · Clinical Cancer Research · 2015 · 294 citations · Full text

Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival

Shaan Dudani, Guillermo de Velasco, J. Connor Wells et al. · JAMA Network Open · 2021 · 273 citations · Full text

Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study

Nieves Martínez Chanzá, Wanling Xie, Mehmet Asım Bilen et al. · The Lancet Oncology · 2019 · 173 citations

Urology, Genitourinary Cancer, Kidney Research +8